Terms: = Liver cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Staging
4 results:
1. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.
Wang T; Dai L; Shen S; Yang Y; Yang M; Yang X; Qiu Y; Wang W
Front Immunol; 2022; 13():843408. PubMed ID: 35693827
[TBL] [Abstract] [Full Text] [Related]
2. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
[TBL] [Abstract] [Full Text] [Related]
3. Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice.
Abshagen K; König M; Hoppe A; Müller I; Ebert M; Weng H; Holzhütter HG; Zanger UM; Bode J; Vollmar B; Thomas M; Dooley S
BMC Syst Biol; 2015 Nov; 9():83. PubMed ID: 26589287
[TBL] [Abstract] [Full Text] [Related]
4. Expression of insulin-like growth factor-II, matrix metalloproteinases, and their tissue inhibitors as predictive markers in the peripheral blood of HCC patients.
El Tayebi HM; Salah W; El Sayed IH; Salam EM; Zekri AR; Zayed N; Salem ES; Esmat G; Abdelaziz AI
Biomarkers; 2011 Jun; 16(4):346-54. PubMed ID: 21506705
[TBL] [Abstract] [Full Text] [Related]
